ANI Pharmaceuticals, Inc. Bottom Line Rises 36% In Q3

(RTTNews) - ANI Pharmaceuticals, Inc. (ANIP) revealed earnings for its third quarter that climbed compared to the same period last year.

The company said its bottom line advanced to $12.68 million, or $1.09 per share. This was higher than $9.29 million, or $0.80 per share, in last year's third quarter.

Analysts had expected the company to earn $1.08 per share, according figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company said revenue for the quarter rose 92.9% to $38.52 million. This was up from $19.97 million last year.

ANI Pharmaceuticals, Inc. earnings at a glance:

-Earnings (Q3): $12.68 Mln. vs. $9.29 Mln. last year. -Earnings Growth (Y-o-Y): 36.5% -EPS (Q3): $1.09 vs. $0.80 last year. -EPS Growth (Y-o-Y): 36.2% -Analysts Estimate: $1.08 -Revenue (Q3): $38.52 Mln vs. $19.97 Mln last year. -Revenue Change (Y-o-Y): 92.9%

-Guidance: Full year EPS guidance: $4.00 - $4.25 Full year revenue guidance: $128 - $134 Mln